Fernanda Sales Luiz Vianna Selected Research

Fetal Diseases (Embryopathy)

7/2023	A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors.
12/2022	Genetic evaluation of HAND2 gene and its effects on thalidomide embryopathy.
1/2021	Comparative Genomics Identifies Putative Interspecies Mechanisms Underlying Crbn-Sall4-Linked Thalidomide Embryopathy.
1/2020	CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation.
1/2019	Assembling systems biology, embryo development and teratogenesis: What do we know so far and where to go next?
1/2018	Genetic susceptibility to thalidomide embryopathy in humans: Study of candidate development genes.
1/2017	Angiogenesis-related genes and thalidomide teratogenesis in humans: an approach on genetic variation and review of past in vitro studies.
12/2016	Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.
3/2016	New Findings in eNOS gene and Thalidomide Embryopathy Suggest pre-transcriptional effect variants as susceptibility factors.
9/2015	Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernanda Sales Luiz Vianna Research Topics

Disease

12	Fetal Diseases (Embryopathy) 07/2023 - 01/2011
7	Teratogenesis 04/2024 - 03/2016
4	Neoplasms (Cancer) 01/2024 - 03/2016
2	Zika Virus Infection 01/2022 - 04/2017
2	Erythema Nodosum 01/2022 - 01/2021
2	Congenital Abnormalities (Deformity) 04/2017 - 01/2011
1	COVID-19 01/2024
1	Adenocarcinoma of Lung 01/2024
1	Leiomyoma (Uterine Fibroids) 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Necrosis 12/2023
1	Neoplasm Metastasis (Metastasis) 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023
1	Li-Fraumeni Syndrome 12/2023
1	Chronic Renal Insufficiency 01/2022
1	Multiple Myeloma 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Leprosy (Hansen's Disease) 01/2011

Drug/Important Bio-Agent (IBA)

15	Thalidomide (Thalomid)FDA Link 04/2024 - 01/2011
5	TeratogensIBA 01/2022 - 09/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2023
2	3' Untranslated Regions (3' UTR)IBA 01/2024 - 12/2023
1	MicroRNAs (MicroRNA)IBA 01/2024
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2024
1	ParaffinIBA 12/2023
1	Formaldehyde (Formol)FDA Link 12/2023
1	Apolipoprotein L1IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	CosmeticsIBA 01/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2018
1	Illicit Drugs (Recreational Drugs)IBA 04/2017
1	Misoprostol (Cytotec)FDA LinkGeneric 04/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	CateninsIBA 01/2017
1	EnzymesIBA 11/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2013
1	tetraethylpyrazine (TEP)IBA 01/2011

Therapy/Procedure

1	Precision Medicine 01/2022